Toth K - Search Results

1

Inhibition of ADP-evoked platelet aggregation by selected poly(ADP-ribose) polymerase inhibitors.

Alexy T, Toth A, Marton Z, Horvath B, Koltai K, Feher G, Kesmarky G, Kalai T, Hideg K, Sumegi B, Toth K. Alexy T, et al. Among authors: toth a, toth k. J Cardiovasc Pharmacol. 2004 Mar;43(3):423-31. doi: 10.1097/00005344-200403000-00014. J Cardiovasc Pharmacol. 2004. PMID: 15076227

2

Hemorheological parameters in coronary artery disease.

Kesmarky G, Toth K, Habon L, Vajda G, Juricskay I. Kesmarky G, et al. Among authors: toth k. Clin Hemorheol Microcirc. 1998 Jul;18(4):245-51. Clin Hemorheol Microcirc. 1998. PMID: 9741664

3

Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.

Szabados E, Fischer GM, Toth K, Csete B, Nemeti B, Trombitas K, Habon T, Endrei D, Sumegi B. Szabados E, et al. Among authors: toth k. Free Radic Biol Med. 1999 Feb;26(3-4):309-17. doi: 10.1016/s0891-5849(98)00199-3. Free Radic Biol Med. 1999. PMID: 9895221

4

Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.

Toth K, Kesmarky G, Vekasi J, Nemes J, Czopf L, Kapronczay P, Halmosi R, Papp E, Juricskay I. Toth K, et al. Clin Hemorheol Microcirc. 1999;21(3-4):209-16. Clin Hemorheol Microcirc. 1999. PMID: 10711745

5

Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.

Toth K, Nemes J, Czopf L, Kapronczay P, Kesmarky G, Juricskay I. Toth K, et al. Clin Hemorheol Microcirc. 1999;20(1):57-61. Clin Hemorheol Microcirc. 1999. PMID: 11185685

6

Hemorheological and oxygen free radical associated alterations during and after percutaneous transluminal coronary angioplasty.

Késmárky G, Tóth K, Vajda G, Habon L, Halmosi R, Róth E. Késmárky G, et al. Among authors: toth k. Clin Hemorheol Microcirc. 2001;24(1):33-41. Clin Hemorheol Microcirc. 2001. PMID: 11345232

7

Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.

Halmosi R, Berente Z, Osz E, Toth K, Literati-Nagy P, Sumegi B. Halmosi R, et al. Among authors: toth k. Mol Pharmacol. 2001 Jun;59(6):1497-505. doi: 10.1124/mol.59.6.1497. Mol Pharmacol. 2001. PMID: 11353811

8

Red blood cell aggregation measurements in whole blood and in fibrinogen solutions by different methods.

Marton Z, Kesmarky G, Vekasi J, Cser A, Russai R, Horvath B, Toth K. Marton Z, et al. Among authors: toth k. Clin Hemorheol Microcirc. 2001;24(2):75-83. Clin Hemorheol Microcirc. 2001. PMID: 11381182

9

The effect of carvedilol on enhanced ADP-ribosylation and red blood cell membrane damage caused by free radicals.

Habon T, Szabados E, Kesmarky G, Halmosi R, Past T, Sumegi B, Toth K. Habon T, et al. Among authors: toth k. Cardiovasc Res. 2001 Oct;52(1):153-60. doi: 10.1016/s0008-6363(01)00359-5. Cardiovasc Res. 2001. PMID: 11557244

10

Scavenger effect of experimental and clinically used cardiovascular drugs.

Marton Z, Halmosi R, Horvath B, Alexy T, Kesmarky G, Vekasi J, Battyany I, Hideg K, Toth K. Marton Z, et al. Among authors: toth k. J Cardiovasc Pharmacol. 2001 Nov;38(5):745-53. doi: 10.1097/00005344-200111000-00011. J Cardiovasc Pharmacol. 2001. PMID: 11602821

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,189 results

Search Page

Filters